The Food and Drugs Authority (FDA) has directed importers, manufacturers, and distributors of mixed drinks containing both alcohol and stimulants — such as caffeine, inositol, glucuronolactone, ginseng, and guarana — to remove these products from the market by the end of March 2026.

The directive follows a post-registration review conducted by the FDA under Sections 81 and 82(a) of the Public Health Act, 2012 (Act 851).

According to the Authority, the review assessed the safety and regulatory compliance of these products, taking into account international and regional precedents where several countries have restricted, suspended, or banned alcoholic energy drinks due to public health concerns.

The FDA stated that scientific evidence indicates that consuming beverages that combine alcohol and stimulants can lead to serious health risks and adverse psychosocial behaviours, particularly among youth, young adults, and unsuspecting consumers.